Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.
1988
Pathophysiology of Progressive Nephropathies
1998 Standout
Bleeding during Thrombolytic Therapy for Acute Myocardial Infarction: Mechanisms and Management
1989
Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients
1995
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy
1998
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology
2004
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys
1993
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Uremic Bleeding: Pathogenesis and Therapy
1998
Renal Failure in the Recipients of Nonrenal Solid Organ Transplants
1999
Fortnightly Review: Glomerulonephritis: diagnosis and treatment
1994
The incidence of renal failure in one hundred consecutive heart-lung transplant recipients
1995
Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion
1993
Hereditary Hemorrhagic Telangiectasia
1995 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
1996
The Aging Kidney: A Review – Part I
2005
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
Liver biopsy†
2008
Transfusion Medicine — Blood Transfusion
1999 Standout
The Effect of Pre-existing Ischaemic Heart Disease on Renal Dysfunction in Cardiac Transplant Recipients
2002
Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade
1999
Hepatitis C infection in two urban hemodialysis units
1990 StandoutNobel
Chronic kidney disease
2011 Standout
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Induction of T Regulatory Cells Attenuates Idiopathic Nephrotic Syndrome
2008 Standout
Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
1990
Acute Renal Failure
1996 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipients
1995
Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury
2000
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
2002
Pathologic Classification of Diabetic Nephropathy
2010 Standout
Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation
2002
The Natural History of Chronic Allograft Nephropathy
2003 Standout
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
The Antiphospholipid Syndrome
2002 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
The Paradox of the Low-Renin State in Diabetic Nephropathy
1999
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
1999
Type 2 Diabetic Patients with Nephropathy Show Structural—Functional Relationships that Are Similar to Type 1 Disease
2000
Risk Factors for Chronic Renal Dysfunction in Cardiac Allograft Recipients
2000
Cyclosporin nephrotoxicity in heart and lung transplant patients
1996
Measuring GFR: A Systematic Review
2014
Sex, haemoglobin and kidney disease: new perspectives
2005
Treatment of the childhood haemolytic uraemic syndrome with plasma
1988
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone
1990
Long‐term renoprotection by perindopril or nifedipine in non‐hypertensive patients with Type 2 diabetes and microalbuminuria
2004
Risk Factors for Cyclosporine-Induced Nephropathy in Patients with Autoimmune Diseases
1992
Patterns of renal injury in NIDDM patients with microalbuminuria
1996
Pathogenesis and treatment of renal failure in multiple myeloma
2008
CYCLOSPORINE-ASSOCIATED END-STAGE NEPHROPATHY AFTER CARDIAC TRANSPLANTATION
1997
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders
1987
Impaired aquaporin and urea transporter expression in rats with adriamycin-induced nephrotic syndrome
1998
Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial
1988
Expansion of Cortical Interstitium Is Limited by Converting Enzyme Inhibition in Type 2 Diabetic Patients with Glomerulosclerosis
1999
Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies
2002
The pathophysiology and management of thrombotic thrombocytopenic purpura
1996
The Hallmarks of Aging
2013 Standout
Recurrent miscarriage
2006 Standout
The red cell transfusion trigger: has a sin of commission now become a sin of omission?
1998
Concentrating defect in experimental nephrotic syndrome: Altered expression of aquaporins and thick ascending limb Na+ transporters
1998
Reversal of chronic cyclosporine nephrotoxicity after heart transplantation—potential role of mycophenolate mofetil
2002
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
1998 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Chronic Kidney Disease
2016 Standout
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
Plasma Infusion as Treatment for 33 Children With Haemolytic Uraemic Syndrome: A Good Therapy ?
1993
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
1989
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome
1984
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy
2000
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
2006
Low-Dose Cyclosporine for the Treatment of Crohn's Disease
1994
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
1989 StandoutNobel
1 Arachidonate Metabolism in Blood Cells and the Vessel Wall
1986
Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells
1994 StandoutNobel
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease
2011
EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN
1982
Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease
2001
Interstitial nephritis induced by protein-overload proteinuria.
1989
The Hypercoagulable States
1985
Vasoactive hormones and renal sclerosis
1996
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
The nephropathy of non-insulin-dependent diabetes
1998
Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant
1982
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids, and hypertension
1995
Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen
1985
Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy
1986
Failure of angiotensin converting enzyme inhibition to affect the course of chronic puromycin aminonucleoside nephropathy.
1987
Multiple Myeloma
2011 Standout
Uncompensated polyuria in a mouse model of Bartter's syndrome
2000 StandoutNobel
Serum levels of free fatty acids in the first trimester of pregnancy: Effect of acetylsalicylic acid
1982
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
2000
Monoclonal Proteins and Renal Disease
1994
Efficacy of several plasma components in a young boy with chronic thrombocytopenia and hemolytic anemia who responds repeatedly to normal plasma infusions
1984
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of G Mecca being referenced
Haemolytic uraemic syndrome: therapeutic effect of plasma infusion.
1982
Hemostasis, prostaglandins, and renal disease
1980
Dialysis versus integrated programme of dialysis and transplantation.
1977
A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies
1991
Plasmatic regulation of vascular prostacyclin in pregnancy.
1981
Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy
1993
Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients
1991
Long-Term Treatment With Either Enalapril or Nitrendipine Stabilizes Albuminuria and Increases Glomerular Filtration Rate in Non- Insulin-Dependent Diabetic Patients
1994
Bleeding in renal failure: is von Willebrand factor implicated?
1977
Outbreak of Non-A, Non-B Hepatitis in Centre Haemodialysis Patients: A Retrospective Analysis
1988
Bleeding in Renal Failure: Altered Platelet Function in Chronic Uraemia only Partially Corrected by Haemodialysis
1978
Heterogeneous nature of renal lesions in type II diabetes.
1993
Conjugated Estrogens for the Management of Bleeding Associated with Renal Failure
1986
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia
1980
MODERATE DOSES OF ASPIRIN AND RISK OF BLEEDING IN RENAL FAILURE
1986
Effect of dietary proteins and lipids in patients with membranous nephropathy and nephrotic syndrome.
1991
Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events.
1982
Management of Myeloma Kidney: An Anti-Light-Chain Approach
1987
Prognosis of untreated patients with idiopathic membranous nephropathy
1994
Prostacyclin and Thrombotic Microangiopathy
1980
Adriamycin-Induced Glomerulosclerosis in the Rat
1986
Bleeding in renal failure: a possible role of vascular prostacyclin (PGI2).
1979
Treatment of the hemolytic uremic syndrome with plasma.
1979
Familial deficiency of a plasma factor stimulating vascular prostacyclin activity
1979
PROSTACYCLIN-LIKE ACTIVITY AND BLEEDING IN RENAL FAILURE
1977
PARATHYROID HORMONE INHIBITS HUMAN PLATELET FUNCTION
1981
Inhibition of Human Platelet Aggregation by Parathyroid Hormone
1985
Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in Uremia
1983
URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS
1982
Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
1996